UPDATE 5-Starboard abandons campaign to scuttle Bristol-Myers-Celgene deal

29 Mar 2019

Activist hedge fund Starboard
Value LP on Friday abandoned a campaign to convince
Bristol-Myers Squibb Co shareholders to vote down the
drugmaker's proposed $74 billion takeover of biotech Celgene
Corp after the two leading proxy advisory firms backed
the deal.

Read full article at Reuters